Supplier
SYMED LABS Ltd.
API List
| Agomelatine | |
| Asenapine Maleate | |
| Brimonidine Tartrate | |
| Carvedilol | |
| Carvedilol Phosphate | |
| Cinitapride Hydrogen Tartrate | |
| Dapoxetine HCl | |
| Deferasirox | |
| Dronedarone HCl | |
| Epalrestat | |
| Eszopiclone | |
| Hydroxyzine HCl | |
| Iloperidone | |
| Iron Dextran Complex | |
| Iron Sucrose | |
| Ketorolac Trometamol | |
| Ketorolac Tromethamine | |
| Lanthanum Carbonate | |
| Levocetirizine DiHCl | |
| Levosulpiride | |
| Linezolid Form II | |
| Linezolid Form III | |
| Meclizine HCl | |
| Mosapride Citrate | |
| Ondansetron HCl Dihydrate | |
| Pregabalin | |
| Retigabine (Ezogabine) | |
| Stanazolol | |
| Tamsulosin HCl | |
| Tapentadol HCl | |
| Thalidomide | |
| Tizanidine HCl | |
| Tofisopam | |
| Vilazodone | |
| Zotepine |
Disclaimer:
Symed Labs Limited strongly believes and supports the intellectual property rights of third parties underlying any commercial product in the pharmaceutical market. Some of the products mentioned in the Symed's Product List/Product brochure as recited in its website may be covered by corresponding existing product patents in India or in any other country concerned. However, mentioning of the name of the said products in the Product List or in the Symed's website shall not be construed as infringement in any manner what so ever.
“Without prejudice to the foregoing, Symed’s supply of the products being covered by valid product patents if any, is intended solely for uses reasonably relating to the development and submission of information required under any law for the time being in force, in India, or in a country other than India that regulates the manufacture, use, sale or import, of the said product, i.e., strictly according to Section 107A of the Indian Patents Act, 1970, as amended in 2005. However the final responsibility lies exclusively with the buyer”